维生素D联合全身振动训练治疗骨肌减少症:随机对照试验研究方案
骨肌减少症是肌少症与骨质疏松症并存的疾病,影响患者生活工作。本研究为多中心平行组临床试验,将受试者随机分入全身振动训练组、维生素D组或联合组,治疗1个月并随访3和6个月,评估联合干预的有效性与安全性并探索疗效机制。
要点
- 维生素D联合全身振动训练治疗骨肌减少症的多中心随机对照试验方案。
- 主要结局为腰椎骨密度、四肢骨骼肌量和握力,次要结局包括血清标志物及体能测试。
- 受试者治疗1个月,随访3和6个月,旨在评估联合干预的有效性与安全性。
核心结论
- 若维生素D联合全身振动训练能良好缓解骨肌减少症症状且无不良反应,该方案可能成为骨肌减少症的新治疗策略。
- 干预后若血清标志物MSTN/irisin变化显著,两者有潜力成为筛选骨肌减少症有效药物和治疗的敏感指标,也提示联合干预通过调节MSTN/irisin改善骨肌减少症。
研究设计与样本
- 多中心、平行组临床试验,评估维生素D联合全身振动训练干预骨肌减少症的有效性与安全性。
- 符合纳入或排除标准并签署知情同意书的受试者被随机分配至全身振动训练组、维生素D组或联合组。
- 所有受试者治疗1个月,并在3和6个月后随访。
关键数值与推荐
- 主要结局为双能X线吸收法测定的腰椎骨密度和四肢骨骼肌量,以及握力计测定的握力。
- 次要结局包括血清肌生成抑制素、鸢尾素和骨转换标志物,SARC-CalF问卷,骨质疏松风险1分钟测试题,SF-36健康调查评估的患者健康状况,以及5次坐立试验、6米步行和简易体能状况量表等体能测量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteo-sarcopenia (OS) has become a global public health problem and a frontier research problem, as a combination of sarcopenia (SP) and osteoporosis (OP) diseases. The clinical performances include muscle weakness, systemic bone pain, standing difficulty, even falls and fractures, etc., which seriously affect the patient's life and work. The pathological mechanism of the OS may be the abnormal metabolism which disrupts the equilibrium stability of the musculoskeletal system. Therefore, this study combined vitamin D (Vit. D) and whole-body vibration training (WBVT) to intervene in subjects of OS, aiming to evaluate the effectiveness and safety of the diagnosis and treatment protocol and to explore the efficacy mechanism. METHODS: We propose a multicenter, parallel-group clinical trial to evaluate the efficacy and safety of Vit. D combined with WBVT intervention in OS. Subjects who met the inclusion or exclusion criteria and signed the informed consent form would be randomly assigned to the WBVT group, Vit. D group, or WBVT+ Vit. D group. All subjects will be treated for 1 month and followed up after 3 and 6 months. The primary outcomes are lumbar bone mineral density (BMD) and appendicular skeletal muscle mass (ASM) measured by dual-energy X-ray absorptiometry (DXA) and handgrip strength measured by grip strength meter. Secondary outcomes include serum markers of myostatin (MSTN), irisin and bone turnover markers (BTM), SARC-CalF questionnaire, 1-min test question of osteoporosis risk, patient health status (evaluated by the SF-36 health survey), physical performance measurement that includes 5-time chair stand test, 6-m walk, and the short physical performance battery (SPPB). DISCUSSION: If Vit. D combined with WBVT can well relieve OS symptoms without adverse effects, this protocol may be a new treatment strategy for OS. After therapeutic intervention, if the serum marker MSTN/irisin is significant, both have the potential to become sensitive indicators for screening OS effective drugs and treatments, which also indicates that WBVT combined with Vit. D plays a role in improving OS by regulating MSTN/irisin. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400082269 . Registered on March 26, 2024.
引用
- Li W, Chen M, Chen F, et al. Vitamin D combined with whole-body vibration training for the treatment of osteo-sarcopenia: study protocol for a randomized controlled trial. Trials. 2024. PMID: 39350307. doi:10.1186/s13063-024-08498-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。